Microwave ablation of hepatocellular carcinoma (IPG214)
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on microwave ablation of hepatocellular carcinoma.
Microwave ablation is a process that uses microwave energy to kill cells. When it is used in the treatment of liver cancer, the energy is applied directly to the tumour through a special needle; the heat from the microwaves destroys the cancer cells
J03.2 Destruction of lesion of liver NEC
Y13.7 Microwave destruction of lesion of organ NOC
J12.7 Percutaneous microwave ablation of lesion of liver
J08.3 Endoscopic microwave ablation of lesion of liver using laparoscope
Note: A code from category Y53.- Approach to organ under image control may also be assigned to these procedures if image control has been used. Codes in category Y53.- are used as secondary codes. If the method of image control is unspecified, Y53.9 Unspecified approach to organ under image control is assigned.
In addition the ICD-10 code C22.0 Liver cell carcinoma or C78.7 Secondary malignant neoplasm of liver and intrahepatic bile duct would be recorded.
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
- IPG 214 Microwave ablation of hepatocellular carcinoma: guidance (web format)
- IPG 214 Microwave ablation of hepatocellular carcinoma: Guidance
- IPG214 Microwave ablation of hepatocellular carcinoma: Understanding NICE guidance
- IPG214 Microwave ablation of hepatocellular carcinoma: Understanding NICE guidance (Word version)
- Microwave ablation of hepatocellular carcinoma: consultation
- Microwave ablation of hepatocellular carcinoma: overview
This page was last updated: 15 June 2012
- Web format
- Full Guidance (PDF)
- IPG214 Trin canser sylfaenol yr iau gydag abladiad microdon: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
- None available
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.